Literature DB >> 34041710

Low Grade Papillary Sinonasal (Schneiderian) Carcinoma: A Series of Five Cases of a Unique Malignant Neoplasm with Comparison to Inverted Papilloma and Conventional Nonkeratinizing Squamous Cell Carcinoma.

Mario W Saab-Chalhoub1, Xingyi Guo2, Qiuying Shi3, Rebecca D Chernock4, James S Lewis5,6,7.   

Abstract

There have been a few case reports and one small series of low grade papillary sinonasal (Schneiderian) carcinomas (LGPSC) which mimic papillomas but have overtly invasive growth and which occasionally metastasize. We describe the morphologic, clinical, immunohistochemical, and molecular features of five patients with LGPSC compared with eight cases each of inverted papilloma (IP) and conventional nonkeratinizing squamous cell carcinoma (SCC) with papillary growth. All LGPSC were nested with predominantly pushing invasion, no stromal reaction, and frequent surface papillary growth. All consisted of one cell type only, with polygonal cells with round nuclei, no (or limited) cytologic atypia, low mitotic activity, and prominent neutrophilic infiltrate. One patient had slightly more infiltrative bone invasion, another lymphovascular, perineural, and skeletal muscle invasion, and a third nodal metastasis after 17 years. By comparison, IPs had bland cytology, neutrophilic microabscesses, mixed immature squamous, goblet cell, and respiratory epithelium, and extremely low mitotic activity. Nonkeratinizing SCCs had basaloid-appearing cells with nuclear pleomorphism, brisk mitotic activity, and apoptosis. All LGPSC were p63 positive. Mitotic activity and Ki67 indices were significantly higher for LGPSCs than IPs and significantly lower than NKSCCs, while p53 immunohistochemistry in LGPSC was identical to nonkeratinizing SCC and higher than for IP. Sequencing showed all five tumors to harbor a MUC6 mutation, one tumor to harbor CDKN2A and PIK3R1 mutations, and one tumor to harbor a NOTCH1 mutation. All LGPSC lacked EGFR and KRAS mutations and lacked copy number variations of any main cancer genes. At a median follow up of 12 months, two LGPSC recurred locally, and one patient died after massive local recurrences and nodal metastases. LGPSC is a distinct, de novo sinonasal carcinoma that can be differentiated from papillomas by morphology and selected immunohistochemistry.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Human papillomavirus; Low grade papillary sinonasal carcinoma; Nonkeratinizing squamous cell carcinoma; Papilloma; Sinonasal; p16

Mesh:

Substances:

Year:  2021        PMID: 34041710      PMCID: PMC8633211          DOI: 10.1007/s12105-021-01335-3

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  27 in total

1.  High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma.

Authors:  Aaron M Udager; Delphine C M Rolland; Jonathan B McHugh; Bryan L Betz; Carlos Murga-Zamalloa; Thomas E Carey; Lawrence J Marentette; Mario A Hermsen; Kathleen E DuRoss; Megan S Lim; Kojo S J Elenitoba-Johnson; Noah A Brown
Journal:  Cancer Res       Date:  2015-04-30       Impact factor: 12.701

2.  Low-Grade Papillary Schneiderian Carcinoma of the Sinonasal Cavity and Temporal Bone.

Authors:  C Scott Brown; Ralph Abi Hachem; Avani Pendse; John F Madden; Howard W Francis
Journal:  Ann Otol Rhinol Laryngol       Date:  2018-09-29       Impact factor: 1.547

3.  Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth.

Authors:  Menachem Fromer; Jennifer L Moran; Kimberly Chambert; Eric Banks; Sarah E Bergen; Douglas M Ruderfer; Robert E Handsaker; Steven A McCarroll; Michael C O'Donovan; Michael J Owen; George Kirov; Patrick F Sullivan; Christina M Hultman; Pamela Sklar; Shaun M Purcell
Journal:  Am J Hum Genet       Date:  2012-10-05       Impact factor: 11.025

4.  Nonkeratinizing Squamous Cell Carcinoma of the Sinonasal Tract With DEK-AFF2: Further Solidifying an Emerging Entity.

Authors:  Justin A Bishop; Jeffrey Gagan; Claire Paterson; Douglas McLellan; Ann Sandison
Journal:  Am J Surg Pathol       Date:  2021-05-01       Impact factor: 6.394

Review 5.  The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.

Authors:  G Mountzios; T Rampias; A Psyrri
Journal:  Ann Oncol       Date:  2014-04-08       Impact factor: 32.976

6.  Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis.

Authors:  Anna Yemelyanova; Russell Vang; Malti Kshirsagar; Dan Lu; Morgan A Marks; Ie Ming Shih; Robert J Kurman
Journal:  Mod Pathol       Date:  2011-05-06       Impact factor: 7.842

Review 7.  Impact of high tumor mutational burden in solid tumors and challenges for biomarker application.

Authors:  Mairéad G McNamara; Timothy Jacobs; Angela Lamarca; Richard A Hubner; Juan W Valle; Eitan Amir
Journal:  Cancer Treat Rev       Date:  2020-07-22       Impact factor: 12.111

8.  Inverted papilloma: a report of 112 cases.

Authors:  W Lawson; B T Ho; C M Shaari; H F Biller
Journal:  Laryngoscope       Date:  1995-03       Impact factor: 3.325

9.  Sinonasal papillomas: clinicopathologic review of 40 patients with inverted and oncocytic schneiderian papillomas.

Authors:  Matthew R Kaufman; Margaret S Brandwein; William Lawson
Journal:  Laryngoscope       Date:  2002-08       Impact factor: 3.325

10.  TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas.

Authors:  Noah A Brown; Komal R Plouffe; Osman Yilmaz; Steven C Weindorf; Bryan L Betz; Thomas E Carey; Raja R Seethala; Jonathan B McHugh; Scott A Tomlins; Aaron M Udager
Journal:  Mod Pathol       Date:  2020-11-17       Impact factor: 8.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.